Does 177Lu-labeled octreotate improve the rate of remission of endocrine gastroenteropancreatic tumors?

Nature clinical practice. Endocrinology & metabolism

Volumn 1, Issue 1, 2005, Pages 20-21

  Eberle, Alex N ^a   Beglinger, Christoph ^a  

^a UNIVERSITY HOSPITAL BASEL   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

(177LUTETIUM DOTA(O)TYR3)OCTREOTATE; (177LUTETIUM-DOTA(O)TYR3)OCTREOTATE; ORGANOMETALLIC COMPOUND; RADIOPHARMACEUTICAL AGENT;

ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; ENDOCRINE TUMOR; HUMAN; KARNOFSKY PERFORMANCE STATUS; METABOLISM; NUCLEAR MAGNETIC RESONANCE IMAGING; PANCREAS TUMOR; RADIATION DOSE; STOMACH TUMOR; TREATMENT OUTCOME;

ENDOCRINE GLAND NEOPLASMS; HUMANS; KARNOFSKY PERFORMANCE STATUS; MAGNETIC RESONANCE IMAGING; ORGANOMETALLIC COMPOUNDS; PANCREATIC NEOPLASMS; RADIATION DOSAGE; RADIOPHARMACEUTICALS; STOMACH NEOPLASMS; TOMOGRAPHY, X-RAY COMPUTED; TREATMENT OUTCOME;

EID: 33748635182     PISSN: 17458366     EISSN: None     Source Type: Journal    
DOI: 10.1038/ncpendmet0028     Document Type: Article

References (0)